Fairchild Semiconductor Reports Results for the Second

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Fairchild Semiconductor Reports Results for the Second Quarter 2014

SAN JOSE, Calif., July 17, 2014 (GLOBE NEWSWIRE) -- Fairchild Semiconductor (Nasdaq: FCS ), a leading global supplier of power semiconductors, today announced results for the second quarter ended June 29, 2014. Fairchild reported second quarter sales of $371.6 million, up 8 percent from the prior quarter and 4 percent higher than the second quarter of 2013.

Fairchild reported second quarter net income of $17.8 million or $0.14 per diluted share compared to a net loss of $9.3 million or $0.07 per diluted share in the prior quarter and a net loss of $7.5 million or $0.06 per diluted share in the second quarter of 2013. Gross margin was 33.4 percent compared to 30.3 percent in the prior quarter and 29.1 percent in the year-ago quarter.

Fairchild reported second quarter adjusted gross margin of 33.4 percent, up 310 basis points from the prior quarter and 360 basis points higher than the second quarter of 2013. Gross margin in quarters prior to the second quarter of 2014 excluded accelerated depreciation related to a line closure. Adjusted net income was $25.2 million or $0.20 per diluted share, compared to adjusted net income of $4.9 million or $0.04 per diluted share in the prior quarter and $1.7 million or $0.01 per diluted share in the second quarter of 2013. See the Reconciliation of Net Income to Adjusted Net Income exhibit included in this press release for more details on the other adjustment items.

"Fairchild continues to deliver steady sales growth due to improved execution and broad-based demand strength," said Mark Thompson, Fairchild's chairman and CEO. "Our distribution sell-through or POS has grown for six consecutive quarters while our weeks of inventory in the channel decreased again to about 9 weeks. We are managing the supply chain very well to maintain short lead times and lean, yet responsive inventory levels to better support our customers. Our current backlog is modestly higher than a quarter ago and we expect to grow sales again in the third quarter. We generated strong cash flow in the second quarter due to improved earnings coupled with low capital spending and favorable changes in working capital. We repurchased 4 percent of our outstanding shares of stock during the second quarter and we plan to continue returning cash to shareholders. 

Second Quarter Financials

"Adjusted gross margin increased 3 points sequentially due to better manufacturing execution in the second quarter and improved product mix," said Mark Frey, Fairchild's executive vice president and CFO. "R&D and SG&A expenses were $98.0 million, up 2 percent sequentially due to the annual merit increase and equity vesting offset by some one-time benefit cost reductions. Free cash flow was a positive $70 million for the second quarter. We ended the second quarter with total cash and securities exceeding our debt by $120 million which was up slightly from the prior quarter despite repurchasing $69 million in stock. This was due to higher net income, lower capital spending and favorable changes in working capital.

Forward Guidance

"We expect sales to be in the range of $370 to $385 million for the third quarter," said Frey. "We expect adjusted gross margin to be 34.0 to 35.0 percent due primarily to higher sales and factory loadings as well as improved product mix. We anticipate R&D and SG&A spending to be $97 to $99 million due to higher variable compensation expenses and lack of the one-time cost benefit in the prior quarter offset by seasonal spending reductions. The adjusted tax rate is forecast at 15 percent plus or minus 3 percentage points for the quarter. Consistent with our usual practices, we are not assuming any obligation to update this information, although we may choose to do so before we announce third quarter results."

Adjusted gross margin, adjusted net income and free cash flow are non-GAAP financial measures and should not be considered replacements for GAAP results. See additional information on our non-GAAP financial measures and reconciliations to the most comparable GAAP measures in the appropriate reconciliation exhibit included in this press release as well as our SEC filings related to this announcement.

Special Note on Forward Looking Statements:

Some of the paragraphs above, including the one headed "Forward Guidance," contain forward-looking statements that are based on management's assumptions and expectations and involve risk and uncertainty. Other forward-looking statements may also be found in this news release. Forward-looking statements usually, but do not always, contain forward-looking terminology such as "we believe," "we expect," or "we anticipate," or refer to management's expectations about Fairchild's future performance. Many factors could cause actual results to differ materially from those expressed in forward-looking statements. Among these factors are the following: failure to maintain order rates at expected levels; failure to achieve expected savings from cost reduction actions or other adverse results from those actions; changes in demand for our products; changes in inventories at our customers and distributors; technological and product development risks, including the risks of failing to maintain the right to use some technologies or failing to adequately protect our own intellectual property against misappropriation or infringement; availability of manufacturing capacity; the risk of production delays; availability of raw materials at competitive prices; competitors' actions; loss of key customers, including but not limited to distributors; the inability to attract and retain key management and other employees; order cancellations or reduced bookings; changes in manufacturing yields or output; risks related to warranty and product liability claims; risks inherent in doing business internationally; changes in tax regulations or the migration of profits from lower tax jurisdictions to higher tax jurisdictions; regulatory risks and significant litigation. These and other risk factors are discussed in the company's quarterly and annual reports filed with the Securities and Exchange Commission (SEC) and available at the Investor Relations section of Fairchild Semiconductor's web site at investor.fairchildsemi.com or the SEC's web site at www.sec.gov .

About Fairchild Semiconductor:

Fairchild has a rich history as a pioneer in the semiconductor industry and that pioneering spirit endures today. In an era where diversity can dilute focus and hamper innovation, we specialize in the development and manufacturing of a complete portfolio of low- to high-power solutions for the mobile, industrial, cloud, automotive, lighting, and computing industries. Fairchild is one of the most reliable partners in the industry, offering the shortest time from concept to silicon, expert FAEs for customer support, and a flexible, multi-source supply chain. Our vision is clear – anticipate the power efficiencies demanded by tomorrow's electronic products and deliver an amazing design experience.

Delivering this vision is Fairchild's way of making the world a cleaner and a better place.  We accomplish this via a deeply human-centric approach: engage our employees, and strive to delight all our customers with great products at a fair price.  If you use a smart phone, drive a car, own a modern appliance, or enjoy film animation you have experienced the power of Fairchild. Fairchild is unique in its deployment of design thinking in conceiving and delivering these advanced products. Our foundation is our guiding principles, which recognizes the inseparability of engaged employees and delighted customers, and encourages our employees to simplify, challenge, explore, play, excel, respect, go fast, and be direct. Please contact us on the web at www.fairchildsemi.com .

 
Fairchild Semiconductor International, Inc.
Consolidated Statements of Operations
(In millions, except per share amounts)
(Unaudited)
           
   Three Months Ended   Six Months Ended 
   June 29,   March 30,   June 30,   June 29,  June 30,
  2014 2014 2013 2014 2013
           
Total revenue  $ 371.6  $ 344.1  $ 356.5  $ 715.7  $ 699.7
Cost of sales (1)  247.4  239.9  252.8  487.3  503.6
Gross margin  124.2  104.2  103.7  228.4  196.1
Gross margin % 33.4% 30.3% 29.1% 31.9% 28.0%
           
Operating expenses:          
Research and development (2)  43.0  41.1  46.0  84.1  88.6
Selling, general and administrative (3)  55.0  55.5  52.2  110.5  103.8
Amortization of acquisition-related intangibles   2.2  4.2  3.9  6.4  7.7
Restructuring, impairments, and other costs  4.7  6.1  3.4  10.8  4.6
Charge for (release of) litigation  --   4.4  --   4.4  (12.6)
Total operating expenses  104.9  111.3  105.5  216.2  192.1
           
Operating income  19.3  (7.1)  (1.8)  12.2  4.0
Other expense, net   2.6  1.1  $ 1.6  3.7  6.2
Income (loss) before income taxes  16.7  (8.2)  (3.4)  8.5  (2.2)
           
Provision (benefit) for income taxes  (1.1)  1.1  4.1  --   5.8
Net income (loss)  $ 17.8  $ (9.3)  $ (7.5)  $ 8.5  $ (8.0)
           
Net income (loss) per common share:          
Basic  $ 0.14  $ (0.07)  $ (0.06)  $ 0.07  $ (0.06)
Diluted   $ 0.14  $ (0.07)  $ (0.06)  $ 0.07  $ (0.06)
Weighted average common shares:          
Basic  122.7  125.4  127.6  124.0  127.4
Diluted  123.9  125.4  127.6  125.6  129.0
           
(1) Equity compensation expense included in cost of sales  $ 1.5  $ 1.0  $ 1.3  $ 2.5  $ 2.4
(2) Equity compensation expense included in research and development  $ 2.1  $ 2.0  $ 2.0  $ 4.1  $ 3.7
(3) Equity compensation expense included in selling, general and administrative  $ 5.2  $ 4.8  $ 4.6  $ 10.0  $ 8.1
           
           
Fairchild Semiconductor International, Inc.
Reconciliation of Net Income To Adjusted Net Income
(In millions)
(Unaudited)
           
   Three Months Ended   Six Months Ended 
   June 29,  March 30, June 30, June 29, June 30,
  2014 2014 2013 2014 2013
           
Net income (loss)  $ 17.8  $ (9.3)  $ (7.5)  $ 8.5  $ (8.0)
Adjustments to reconcile net income (loss) to adjusted net income (loss):          
Restructuring, impairments, and other costs  4.7  6.1  3.4  10.8  4.6
Write off of equity investments  --  --  --  --  3.0
Accelerated depreciation on assets related to line closure (1)  --  --  2.5  --  5.4
Write down of asset held for sale  1.9  --  --  1.9  --
Gain on sale of equity investment  (1.4)  --  --  (1.4)  --
Charge for (release of) litigation  --  4.4 --  4.4  (12.6)
Amortization of acquisition-related intangibles  2.2  4.2  3.9  6.4  7.7
Associated net tax effects of the above and other acquisition-related intangibles  --  (0.5)  (0.6)  (0.5)  (0.4)
Adjusted net income (loss)  $ 25.2  $ 4.9  $ 1.7  $ 30.1  $ (0.3)
           
Adjusted net income (loss) per common share:          
Basic  $ 0.21  $ 0.04  $ 0.01  $ 0.24  $ (0.00)
Diluted  $ 0.20  $ 0.04  $ 0.01  $ 0.24  $ (0.00)
           
(1) Recorded in cost of sales          
           
 
Fairchild Semiconductor International, Inc.
Reconciliation of Gross Margin To Adjusted Gross Margin
(In millions)
(Unaudited)
           
   Three Months Ended   Six Months Ended 
   June 29,  March 30, June 30, June 29, June 30,
  2014 2014 2013 2014 2013
           
Gross margin  $ 124.2  $ 104.2  $ 103.7  $ 228.4  $ 196.1
Adjustments to reconcile gross margin to adjusted gross margin:          
Accelerated depreciation on assets related to line closure  --   --   2.5  --   5.4
Adjusted gross margin  $ 124.2  $ 104.2  $ 106.2  $ 228.4  $ 201.5
           
Adjusted gross margin % 33.4% 30.3% 29.8% 31.9% 28.8%
 
 
Fairchild Semiconductor International, Inc.
Consolidated Balance Sheets
(In millions)
(Unaudited)
       
  June 29, March 30, December 29,
  2014 2014 2013
       
ASSETS    
Current assets:      
Cash and cash equivalents  $ 317.4  $ 315.8  $ 417.8
Short-term marketable securities  0.2  0.2  0.1
Receivables, net  148.6  158.7  127.4
Inventories  234.4  221.9  228.1
Other current assets  50.2  47.1  51.2
Total current assets  750.8  743.7  824.6
       
Property, plant and equipment, net  674.7  693.2  707.9
Intangible assets, net  42.9  45.1  31.7
Goodwill  213.7  210.2  169.3
Long-term securities  2.2  2.1  2.2
Other assets  63.1  65.6  60.3
Total assets  $ 1,747.4  $ 1,759.9  $ 1,796.0
       
LIABILITIES, TEMPORARY EQUITY AND STOCKHOLDERS' EQUITY    
Current liabilities:      
Accounts payable  $ 125.6  $ 106.1  $ 95.8
Accrued expenses and other current liabilities  84.7  73.0  88.0
Total current liabilities  210.3  179.1  183.8
       
Long-term debt, less current portion  200.1  200.1  200.1
Other liabilities  57.3  56.6  48.0
Total liabilities  467.7  435.8  431.9
       
Temporary equity - deferred stock units  3.0  3.9  3.6
Total stockholders' equity  1,276.7  1,320.2  1,360.5
Total liabilities, temporary equity and stockholders' equity  $ 1,747.4  $ 1,759.9  $ 1,796.0
 
 
Fairchild Semiconductor International, Inc.
Consolidated Statements of Cash Flows
(In millions)
(Unaudited)
       
   Three Months Ended   Six Months Ended 
  June 29, June 29, June 30,
  2014 2014 2013
Cash flows from operating activities:      
Net income (Loss)  $ 17.8  $ 8.5  $ (8.0)
Adjustments to reconcile net income (loss) to cash provided by operating activities:      
Depreciation and amortization  32.0  68.0  72.5
Non-cash stock-based compensation expense  8.8  16.6  14.2
Non-cash restructuring and impairments expense  --   0.6  --
Gain on sale of equity investment  (1.4)  (1.4)  --
Deferred income taxes, net  (7.8)  (4.7)  1.4
Charge for (release of) litigation  --   4.4  (12.6)
Other  2.0  2.4  4.3
Changes in operating assets and liabilities, net of acquisitions  33.4  (1.0)  (25.6)
Cash provided by operating activities  84.8  93.4  46.2
       
Cash flows from investing activities:      
Capital expenditures  (15.2)  (28.9)  (40.1)
Proceeds from sale of equity investment  2.1  2.1 --
Maturity of marketable securities  0.5  --   0.1
Other  (1.4)  (1.4)  (1.1)
Acquisitions, net of cash acquired  (0.2)  (60.0)  --
Cash used in investing activities   (14.2)  (88.2)  (41.1)
       
Cash flows from financing activities:      
Proceeds from issuance of common stock and from exercise of stock options, net   0.5  0.7  0.5
Purchase of treasury stock  (68.9)  (99.5)  (8.7)
Shares withheld for employees taxes  (0.6)  (6.8)  (8.0)
Cash used in financing activities  (69.0)  (105.6)  (16.2)
       
Net change in cash and cash equivalents  1.6  (100.4)  (11.1)
Cash and cash equivalents at beginning of period  315.8  417.8  405.9
Cash and cash equivalents at end of period  $ 317.4  $ 317.4  $ 394.8
       
       
Fairchild Semiconductor International, Inc.
Reconciliation of Cash Provided (Used in) by Operating Activities to Free Cash Flow
(In millions)
(Unaudited)
       
   Three Months Ended   Six Months Ended 
  June 29, June 29, June 30,
  2014 2014 2013
       
Cash provided by (used in) operating activities  $ 84.8  $ 93.4  $ 46.2
Capital expenditures  (15.2)  (28.9)  (40.1)
Free cash flow  $ 69.6  $ 64.5  $ 6.1

Editorial Contacts Dan Janson Investor Relations (207) 775-8660 Sajal Sahay WW Corporate Marketing (408) 221-9615

Scroll down for more posts ▼

Top 10 Most Recent News Articles

JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 232

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West

Updated Category News Views 290

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 373

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 104

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 38

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 675

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 144

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 136

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 607

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 21

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading

Top 5 Most Recently Viewed Articles

Cassava Sciences Takes Strategic Steps Amid Clinical Developments

Updated Category News Views 241

Cassava Sciences Provides Key Business Update Cassava Sciences, Inc. (NASDAQ: SAVA), a biotechnology company dedicated to developing innovative treatments for central nervous system disorders, has shared an important business update that affects both its operations and strategic direction. Important Study Results and Future Plans Recent data from the Phase 3 RETHINK-ALZ...

Continue Reading
ColdVentures Welcomes Dr. Barrak Alahmad as Strategic Advisor

Updated Category News Views 164

ColdVentures Expands Leadership with Key Appointment ColdVentures, a pioneering medical device company focused on addressing heat-related illnesses, has taken a significant step forward by appointing Dr. Barrak Alahmad as a strategic advisor. Dr. Alahmad, known for his expertise in environmental health and climate change, brings a wealth of knowledge to the role,...

Continue Reading
Season Group Hits Top 15% with EcoVadis Silver Medal

Updated Category News Views 40

Season Group's Silver Medal Moment Well, it's not every day that a company gets a pat on the back for actually doing something good, but that's what you have here with Season Group snagging the EcoVadis Silver Medal. It’s like the Oscars for sustainability, and it puts them in the top 15% of companies assessed globally by these sustainability gurus. That’s a title...

Continue Reading
LSPedia Achieves Notable Recognition in Business Category

Updated Category News Views 144

LSPedia Celebrated for Excellence in Business LSPedia is thrilled to announce its recent inclusion in Inc.'s 2024 Best in Business list, specifically in the Software as a Service category. This prestigious recognition highlights organizations that are industry leaders and stand out for their impactful achievements. A Testament to Industry Leadership In recognizing...

Continue Reading
Bev Colan Appointed as President of Venn Workforce Optimization

Updated Category News Views 216

Venn Workforce Optimization Welcomes New Leadership In an exciting development for Venn Workforce Optimization, Bev Colan has been named the company president. This marks a significant step for the organization, which specializes in locum tenens optimization and workforce solutions technology. Bev Colan: A Proven Leader Bev Colan joins the Venn team with over 20 years of...

Continue Reading